Preprint2023
SLC10A2 has prognostic implications for individuals afflicted with diabetic pancreatic cancer, and its associated molecules have the potential to serve as biomarkers for diabetic nephropathy
- Published
- 6 December 2023
- Citations
- 0
- Type
- Preprint
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Abstract Background Diabetic nephropathy (DN)is the primary precipitant of renal failure. Nevertheless, the gene expression profile of the kidney in diabetic nephropathy remains inadequately scrutinized, resulting in a paucity of robust diagnostic markers and therapeutic targets for DN. … Excerpt only: this text is the publisher’s. Read it in full at the source.